Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Nov 15, 2011 · 10-Q · 46 days after period end · 0001144204-11-064907
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $251.83K | $359.94K |
| Net Income | -$661.76K | -$640.74K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 15, 2011 · 46 d after period end
